July 16 (Reuters) - Swedish Orphan Biovitrum AB (publ)
SOBIV.ST :
* OUTLOOK 2024: REVENUE IS ANTICIPATED TO GROW BY LOW
DOUBLE-DIGIT
PERCENTAGE AT CER (PREVIOUSLY HIGH SINGLE-DIGIT)
* OUTLOOK 2024: ADJUSTED EBITA MARGIN IS ANTICIPATED TO BE
IN
MID-30S PERCENTAGE OF REVENUE (UNCHANGED)
* Q2 EBITA WAS SEK 1,486 M (1,009), CORRESPONDING TO A
MARGIN OF
27 PER CENT (21)
Source text for Eikon: ID:nWkr8gDCRk
Further company coverage: SOBIV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))